Gritstone bio, Inc.
GRTS · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $83,112 | $278,219 | $199,074 | $198,389 |
| - Cash | $52,174 | $43,642 | $65,285 | $29,539 |
| + Debt | $102,494 | $103,282 | $104,775 | $95,301 |
| Enterprise Value | $133,432 | $337,859 | $238,564 | $264,151 |
| Revenue | $57 | $49 | $29 | $1,565 |
| % Growth | 16.3% | 69% | -98.1% | – |
| Gross Profit | -$1,543 | -$1,693 | -$1,892 | -$399 |
| % Margin | -2,707% | -3,455.1% | -6,524.1% | -25.5% |
| EBITDA | -$20,492 | -$37,347 | -$27,679 | -$35,479 |
| % Margin | -35,950.9% | -76,218.4% | -95,444.8% | -2,267% |
| Net Income | -$23,396 | -$40,385 | -$30,818 | -$38,434 |
| % Margin | -41,045.6% | -82,418.4% | -106,269% | -2,455.8% |
| EPS Diluted | -0.16 | -0.34 | -0.32 | -0.33 |
| % Growth | 52.9% | -6.3% | 3% | – |
| Operating Cash Flow | -$26,811 | -$33,567 | -$34,375 | -$31,087 |
| Capital Expenditures | -$32 | -$143 | -$191 | -$1,093 |
| Free Cash Flow | -$26,843 | -$33,710 | -$34,566 | -$32,180 |